India’s Pharma Exports Face High Risk Amid US Tariff
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Abbott India
Read More
October 28, 2026
- Blood Bank Licensing Goes Fully Digital, Approval Timeline Reduced to Four Months
- UP Cabinet Approves PPP Model for Four Government Hospitals, Including Bareilly’s 300-Bed Facility
- Supreme Court Questions High Medicine Markups, Criticises Centre Over Drug Pricing Regulation
- Chinese-Russian Team Performs Experimental Spinal Cord Transplant in Paralysed Patient